logo

For the Inventor, By the Inventor

Strasbourg, France

Anne-Marie Aubertin

This inventor holds 4 USPTO granted patents. Top assignees: Centre National De La Recherche Scientifique, Emory University, The UAB Research Foundation (The University of Alabama at Birmingham). Active years: 2000-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne-Marie Aubertin. Retrieved from https://idiyas.com/inventor/anne-marie-aubertin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4

% Patents Active = 50.0

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:

goldMedal2 out of 5,383 
 
Centre National De La Recherche Scientifique
 patents
silverMedal1 out of 1,024 
 
Emory University
 patents
bronzeMedal1 out of 641 
 
The UAB Research Foundation (The University of Alabama at Birmingham)
 patents
4. 2 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 2000-2008

Loading Chart...
4 patents (USPTO):Explore Patents
1. 7439351 - 2' or 3′ -deoxy and 2′, 3′-dideoxy-β-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti-viral agents (2008-10-21),
2. 6683079 - 3-(amino-or aminoalkyl) pyridinone derivatives and their use for the treatment of HIV related diseases (2004-01-27),
3. 6451822 - 3-(Amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of HIV related diseases (2002-09-17),
4. 6015820 - 4-Aryl-thio-pyridin-2(1H)-ones, medicines containing them and their uses (2000-01-18),

Title: Anne-Marie Aubertin: Innovator in Antiviral Compounds

Introduction

Anne-Marie Aubertin is a prominent inventor based in Strasbourg, France. She has made significant contributions to the field of antiviral agents, particularly through her innovative work on nucleoside compounds. With a total of 4 patents, her research has the potential to impact therapeutic applications significantly.

Latest Patents

Aubertin's latest patents focus on the development of 2' or 3′-deoxy and 2′, 3′-dideoxy-β-L-pentofuranonucleoside compounds. These compounds are notable for their method of preparation and application in therapy, especially as anti-viral agents. Additionally, her work includes the stereospecific preparation of these compounds, which are described as crucial for their use as drugs, particularly 2′,3′-dideoxy-β-L-fluorocytidine, aimed at treating viral infections.

Career Highlights

Throughout her career, Aubertin has worked with esteemed institutions, including the Centre National de la Recherche Scientifique. Her research has been pivotal in advancing the understanding and treatment of HIV-related diseases through innovative chemical compounds.

Collaborations

Aubertin has collaborated with notable colleagues such as Emile R. Bisagni and Chi Hung Nguyen. Their combined expertise has contributed to the successful development of her patented compounds.

Conclusion

Anne-Marie Aubertin's work exemplifies the intersection of innovation and therapeutic application in the field of antiviral research. Her contributions continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…